UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037605
Receipt number R000042880
Scientific Title Muticenter trial on Apixavan or Edoxiavan for postoperative atrial fibrillation: A prospective cohort study
Date of disclosure of the study information 2019/08/06
Last modified on 2019/08/06 15:31:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Muticenter trial on Apixavan or Edoxiavan for postoperative atrial fibrillation: A prospective cohort study

Acronym

Muticenter trial on Apixavan or Edoxiavan for postoperative atrial fibrillation: A prospective cohort study

Scientific Title

Muticenter trial on Apixavan or Edoxiavan for postoperative atrial fibrillation: A prospective cohort study

Scientific Title:Acronym

Muticenter trial on Apixavan or Edoxiavan for postoperative atrial fibrillation: A prospective cohort study

Region

Japan


Condition

Condition

partial atrial fibrillation after cardiac surgery

Classification by specialty

Cardiology Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to elucidate the effectiveness and problems of Apixavan and Edoxiavan for atrial fibrillation after cardiac surgery.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase IV


Assessment

Primary outcomes

Bleeding event
Thromboembolic event

Key secondary outcomes

1) Hb, Ht, BUN, Cr, eGFR, AST, ALT
2) PT-INR, APTT
3) uric blood
4) Blood loss from drain, blood transfusion


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

atrial fibrillation after cardiac surgery
Patients from whom informed consent was obtained

Key exclusion criteria

Patients from whom informed consent was not obtained
Hemodialysis
Car<15
valve replacement surgery
Doctor's decision not to register to this regimen

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Akira
Middle name
Last name Sezai

Organization

Nihon University School of Medicine

Division name

Department of Cardiovascular Surgery

Zip code

1738610

Address

30-1 Oyaguchi kami-machi, Itabashi-ku, Tokyo, Japan

TEL

03-3972-8111

Email

asezai.med@gmail.com


Public contact

Name of contact person

1st name Akira
Middle name
Last name Sezai

Organization

Nihon University School of Medicine

Division name

Department of Cardiovascular Surgery

Zip code

1738610

Address

30-1 Oyaguchi kami-machi, Itabashi-ku, Tokyo, Japan

TEL

03-3972-8111

Homepage URL


Email

asezai.med@gmail.com


Sponsor or person

Institute

Nihon University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Nihon University Hospital, Tokyo Rinkai Hospital, Kawaguchi Municipal Medical Center, Sagamihara Kyodo Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

none

Address

none

Tel

none

Email

none


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

日大板橋病院(東京都)、日本大学病院(東京都)、東京臨海病院(東京都)、川口医療センター(埼玉県)、相模原協同病院(神奈川県)


Other administrative information

Date of disclosure of the study information

2019 Year 08 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2018 Year 10 Month 01 Day

Date of IRB

2019 Year 04 Month 05 Day

Anticipated trial start date

2019 Year 09 Month 01 Day

Last follow-up date

2022 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Prospective cohort study


Management information

Registered date

2019 Year 08 Month 06 Day

Last modified on

2019 Year 08 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042880


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name